MENU
BTAI
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
BioXcel Therapeutics (BTAI) Ownership - Who owns BioXcel Therapeutics?
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
555 Long Wharf Drive
Phone
+1 475 238-6837
Employees
74
Web
https://www.bioxceltherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
9.45M
P/E Ratio
N/A
Total Cash
31.01M
Projected Growth
N/A
Total Debt
105.88M
Revenue
1.85M
Risk (Beta)
-0.42
Dividend Yield
N/A
Total Cash/Share
5.12
Total Debt/Equity
N/A
Revenue/Share
0.57 USD as % of share price
Fundamentals
BTAI
Capitalization
9.45M
P/E Ratio
N/A
Risk (Beta)
-0.42
Dividend Yield
N/A
Total Cash
31M
Total Cash/Share
5.12
Total Debt
106M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.57%
Revenue
1.85M
ROE
N/A
Book Value
-90.17M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-11.12
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
59K
Current Ratio
1.48
Current Revenue Per Employee
4540.54
Dividends Per Share - Security
N/A
EBITDA
-24.24M
Float
N/A
Float - Current
N/A
Gross Income Margin
91.67
Revenue To Assets
-66.28
Shares Held By Institutions
889K
Shares Outstanding - Current
6.06M
Total Liabilities
129M
Total Volume MTD
N/A
Value
-1
Gain YTD
-73.924
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a biopharmaceutical company
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
555 Long Wharf Drive
Phone
+1 475 238-6837
Employees
74
Web
https://www.bioxceltherapeutics.com